{"artifact_id":"open_question-642754e6-5f66-4f8a-a2c6-efaa408bca05","artifact_type":"open_question","title":"How can Clinical trials, Biomarkers signals be standardized across cohorts and sites without losing disease-stage sensitivity?","quality_score":0.5,"is_latest":1,"version_number":1,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{},"total_incoming":0,"outgoing_by_type":{"derives_from":1,"partial_answer_for":2,"bears_on_question":8},"total_outgoing":11,"quality_trajectory":[{"score":0.5,"at":"2026-04-27T06:50:44.589337-07:00"},{"score":0.5,"at":"2026-04-26T23:44:36.179837-07:00"}],"evidence_balance":0.0,"evidence_certainty":0.0,"total_evidence_items":11,"is_well_supported":false,"is_controversial":false,"is_foundational":false}